News
Interest in the Johor-Singapore Special Economic Zone has been high amid geopolitical uncertainties and businesses that have ...
New U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight's unique value propositionUpsized $20 million financing ...
Noting the Chinese government has always prioritized people's well-being and firmly safeguards public food safety, Lin said ...
Aligning with EU on genetically modified food and agricultural products will create a regulatory cliffedge for a sector which ...
Japan pledged to take credible and transparent measures to ensure the quality and safety of its aquatic products meet China’s ...
Hong Kong-listed shares of the company behind hits like Eggy Party are now less than 3% away from their 2021 record. The ...
Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, ...
Beijing is investigating Bi Jingquan, a deputy chief of the economic affairs committee under China’s top political advisory ...
StockStory.org on MSN1d
A Q2 Earnings Call: Mixed Revenue Performance, Margin Pressure, and Strategic UpdatesLife sciences tools company Agilent Technologies (NYSE:A) in Q1 CY2025, but sales rose 6% year on year to $1.67 billion. Its ...
Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...
Regulators will review data on satri-cel's ability to treat advanced Claudin18.2-positive tumors in an expedited timeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results